BridgeBio
North America, California, United States, Palo Alto
Description
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Investor Profile
BridgeBio has made 3 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (67%)
- Series Unknown (33%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
